Together, they mitigate CDK5-induced neurodegeneration by regulating Tau hyperphosphorylation, oxidative stress, and neuronal apoptosis, making FAM110B and YWHAE potential therapeutic targets in Alzheimer’s disease. Here, YWHAE is linked to early-onset autosomal dominant Alzheimer disease.